Cyclophosphamide in the Treatment of Idiopathic Pulmonary Fibrosis
- 1 June 2000
- Vol. 117 (6) , 1619-1626
- https://doi.org/10.1378/chest.117.6.1619
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Diagnostic and Management Strategies for Diffuse Interstitial Lung DiseaseChest, 1998
- Corticosteroids and the Treatment of Idiopathic Pulmonary FibrosisChest, 1996
- Determinants of survival in idiopathic pulmonary fibrosis.American Journal of Respiratory and Critical Care Medicine, 1994
- Determinants of progression in idiopathic pulmonary fibrosis.American Journal of Respiratory and Critical Care Medicine, 1994
- Idiopathic Pulmonary Fibrosis: Current Clinical Concepts and Challenges in ManagementSeminars in Respiratory and Critical Care Medicine, 1994
- Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up.Thorax, 1992
- Azathioprine Combined with Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Prospective Double-blind, Randomized, Placebo-controlled Clinical TrialAmerican Review of Respiratory Disease, 1991
- Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.Thorax, 1989
- Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survivalThorax, 1980